1,565.75
-10.95
(-0.69%)
At close: 3:28:47 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
Total Revenue
1,719,190
1,719,190
387,140
Cost of Revenue
705,090
705,090
204,110
Gross Profit
1,014,100
1,014,100
183,030
Operating Expense
2,579,350
2,579,350
2,341,850
Operating Income
-1,565,250
-1,565,250
-2,158,820
Net Non Operating Interest Income Expense
-875,310
-875,310
-459,660
Pretax Income
-3,656,970
-3,656,970
-4,156,450
Net Income Common Stockholders
-3,911,650
-3,911,650
-7,998,300
Diluted NI Available to Com Stockholders
-3,911,650
-3,911,650
-7,998,300
Basic EPS
--
-34.18
-69.89
Diluted EPS
--
-34.18
-69.89
Basic Average Shares
--
114,436.02
114,436.02
Diluted Average Shares
--
114,436.02
114,436.02
Rent Expense Supplemental
26,850
26,850
10,840
Total Expenses
3,284,440
3,284,440
2,545,960
Net Income from Continuing & Discontinued Operation
-3,911,650
-3,911,650
-7,998,300
Normalized Income
-2,438,740
-2,438,740
-2,708,920
Interest Income
19,170
19,170
15,790
Interest Expense
853,990
853,990
401,060
Net Interest Income
-875,310
-875,310
-459,660
EBIT
-2,802,980
-2,802,980
-3,755,390
EBITDA
-1,849,180
-1,849,180
-2,614,380
Reconciled Cost of Revenue
705,090
705,090
204,110
Reconciled Depreciation
953,800
953,800
1,141,010
Net Income from Continuing Operation Net Minority Interest
-3,656,970
-3,656,970
-4,156,450
Total Unusual Items Excluding Goodwill
-1,218,230
-1,218,230
-1,447,530
Total Unusual Items
-1,218,230
-1,218,230
-1,447,530
Normalized EBITDA
-630,950
-630,950
-1,166,850
3/31/2023 - 1/24/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MDER Medera Inc
BINV.ST BioInvent International AB (publ)
27.60
+2.41%
VICO.ST Vicore Pharma Holding AB (publ)
6.32
0.00%
BLUEJET.NS Blue Jet Healthcare Limited
762.20
+1.99%
MLYS Mineralys Therapeutics, Inc.
13.50
-2.74%
YMAB Y-mAbs Therapeutics, Inc.
4.5400
-15.14%
RPRX Royalty Pharma plc
32.19
-0.80%
AXSM Axsome Therapeutics, Inc.
104.47
+0.62%